News

CombinatoRx shows data from its first biologic/small molecule High Throughput Screening effort identifying drug classes that synergistically enhance the activity of the oncology-relevant cytokine TNF-related apoptosis.

The Company has appointed senior pharmaceutical industry professionals to establish its own personalized medicines operations in US.

Philochem to apply its DNA-encoded libraries to the discovery of low molecular weight compounds against three undisclosed targets of pharmaceutical interest.

BioFocus DPI will perform high throughput screening for Ono's drug discovery program and will apply its medicinal chemistry and ADME expertise in multiple medicinal chemistry projects.

Expression Analysis will provide gene expression and genotyping services for EPA's ToxCast™ Program.

The Puerto Rico facility will support the long-term supply of Abbott’s biologic agent, HUMIRA®, and other future biologics.

Bionas closes a financing deal to fund sales, marketing and product expansion, GENIUS Venture Capital GmbH and the KfW-Bankengruppe also participated in the financing.

Caliper will conduct certain in vivo profiling experiments that will enable Pfizer to explore new indications for some compounds in its research and development pipeline.

Phylonix will profile biological toxins by using zebrafish test system under a two-year contract with $4.3 million award under the agency’s ToxCast™ project.

The article develops a theoretical basis for the unique effects that microwave energy has on biomolecules and interaction of proteins and biomolecules with microwaves.